DT Capital Limited (00356.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 17Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15

Key dataSep 15, 2026

OpenHKD 0.47

From 52W high−19.66%

Volume0.00

Market capHKD 1.29B

P/E (TTM)—

P/S (TTM)894.9x

Div yield—

Key dataSep 15, 2026

Open

HKD 0.47

From 52W high

−19.66%

Volume

0.00

Market cap

HKD 1.29B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2578.6x

P/E (TTM)

—

RSI (14)

41.6

MomentumView details →

1D Return

−6.00%

YTD Return

+571.43%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−2578.6x

EV/Sales

844.3x

P/S (TTM)

894.9x

P/B (TTM)

17.4x

ProfitabilityView details →

Gross Margin

100.00%

Net Margin

−35.59%

EBITDA Margin

−32.74%

ROE (TTM)

−0.69%

ROA (TTM)

−0.68%

Asset Turnover

0.02x

GrowthView details →

Revenue YoY

−63.63%

EPS YoY

—

FCF YoY

+2604.21%

Revenue CAGR 3Y

+254.09%

EPS CAGR 3Y

+115.91%

EBITDA YoY

+95.15%

MomentumView details →

1D Return

−6.00%

YTD Return

+571.43%

1Y Return

+552.78%

RSI (14)

41.6

vs 50D SMA

−6.34%

vs 200D SMA

+138.68%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

95.95x

Quick Ratio

95.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

5.39M

Net Income (TTM)

−10.58M

Op. CF (TTM)

409941.00

Latest newsMore news →

Suzhou Furon Biotechnology completed a Pre-B+ financing round raising nearly RMB 100 million, led by Fujian Capital New Drug Fund.4d ago

Dingli Capital announced its interim results for the six months ended June 30, 2026, with revenue of HKD 280,000 and a net loss widening to HKD 4.31 million from HKD 1.77 million a year earlier.28d ago

Similar companies

LFG Investment Holdings Limited03938.HK Gold.com, Inc.GOLD Oppenheimer Holdings Inc.OPY Shenwan Hongyuan (H.K.) Limited00218.HK Bitfarms Ltd.BITF Donnelley Financial Solutions, Inc.DFIN Find similar companies →

Latest newsMore news →

Suzhou Furon Biotechnology completed a Pre-B+ financing round raising nearly RMB 100 million, led by Fujian Capital New Drug Fund.4d ago Dingli Capital announced its interim results for the six months ended June 30, 2026, with revenue of HKD 280,000 and a net loss widening to HKD 4.31 million from HKD 1.77 million a year earlier.28d ago